Contraceptive vaccine male reversible - IMMUCON

Drug Profile

Contraceptive vaccine male reversible - IMMUCON

Alternative Names: P26h vaccine; Reversible male contraceptive vaccine - IMMUCON

Latest Information Update: 26 Jan 2015

Price : $50

At a glance

  • Originator IMMUCON
  • Class Contraceptives; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Contraception

Most Recent Events

  • 26 Jan 2015 Discontinued - Preclinical for Contraception/Pregnancy (Prevention) in Canada (Parenteral)
  • 20 Feb 2006 No development reported - Preclinical for Contraception/Pregnancy (Prevention) in Canada (Parenteral)
  • 30 Aug 2002 This agent is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top